Immunohistochemical analysis confirmed that Sharpin expression was mainly observed in the cytoplasm and was significantly higher in HCC than in surrounding noncancerous liver tissue (P<0.05, Wilcoxon signed-rank test; Figure 1d). This evidence concerns the gene SHARPIN and hepatocellular carcinoma.